Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

New publication date for Sectra’s six-month report in December 2016

Posted on: 30 Sep 16
Linköping, Sweden, September 30, 2016 – The Board of Directors of IT and medical technology company Sectra AB (STO: SECT B) has decided to postpone the publication of the company’s six-month report for the May-October 2016 period until 8:00 a.m. on December 12, 2016. The report was originally scheduled for publication on December 7, 2016. The decision to change the publication date was made to enable Sectra’s employees and any persons discharging managerial responsibilities in the company to redeem the convertibles subscribed for in 2013 on November 7-10, 2016, and to subscribe for new convertibles on November 7-11, 2016, in accordance with a resolution by the 2016 Annual General Meeting (AGM). This decision is linked to the EU Market Abuse Regulation (MAR), which came into force in July 2016. Under MAR, the rules for persons discharging managerial responsibilities have been changed and now stipulate a 30-day “closed period” prior to the publication of interim reports, during which persons discharging managerial responsibilities are prohibited from conducting transactions related to shares or debt instruments issued by the company. Since Sectra has a convertible program for all of its employees, which was introduced before the new rules were announced, the report must be postponed for a week in order to enable the program to be carried out. Presentation of the six-month report In conjunction with the publication of the six-month report, Sectra plans to hold a teleconference for analysts, investors and the media. Time: Monday, December 12 at 10:00 a.m. (CET). Sectra’s financial reporting calendar for the 2016/2017 fiscal year · Six-month report on December 12, 2016 at 8:00 a.m. CET. · Nine-month report on March 7, 2017, at 8:00 a.m. CET. · Year-end report 2016/2017 on May 30, 2017, at 8:00 a.m. CET. Subscribe for information To subscribe for financial reports, invitations and information from Sectra via e-mail, please fill in your information at ( This information is information that Sectra AB (publ) is obliged to make public. The information was submitted to the media for publication, through the agency of the contact person set out below, at 8:10 a.m. CET on September 30, 2016. For further information, please contact: Dr. Torbjörn Kronander, CEO and President Sectra AB, 46 (0) 705 23 52 27 Press photos: ( a lsystems) About Sectra The world needs more efficient healthcare and increased security in society’s communication and IT systems. Sectra plays a key role in meeting these needs. Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company was founded in 1978, has its head office in Linköping, Sweden, with subsidiaries in 14 countries, and operates through partners worldwide. Sales in the 2015/2016 fiscal year totaled SEK 1,073 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit

Last updated on: 03/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.